Evaluation of MYD88 p.L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B-cell lymphoma of the central nervous system.
作者信息
Harlay Vincent, Gallardo Catherine, Beaufils Nathalie, Astier Alexandre, Testud Benoit, Amri Amira, Fritz Shirley, Abbou Norman, Robert Philippe, Garcia Jeremy, Roll Patrice, Ouafik L'houcine, Schenone Laurence, Petrirena Gregorio, Bertucci Alexandre, Bequet Céline, Chinot Olivier, Tabouret Emeline, Nanni Isabelle, Appay Romain, Kaspi Elise, Frankel Diane
机构信息
Neuro-Oncology Department, Aix-Marseille University, APHM, University Hospital Timone, Marseille, France.
Anatomocytopathology Department, APHM, M2GM, University Hospital Timone, Marseille, France.
出版信息
Br J Haematol. 2025 May 25;207(1):289-93. doi: 10.1111/bjh.20167.
Abstract
摘要
相似文献
1
Evaluation of MYD88 p.L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B-cell lymphoma of the central nervous system.
Br J Haematol. 2025 May 25;207(1):289-93. doi: 10.1111/bjh.20167.
2
Effectiveness of digital PCR for MYD88 detection in vitreous fluid for primary central nervous system lymphoma diagnosis.
Exp Ther Med. 2020 Jul;20(1):301-308. doi: 10.3892/etm.2020.8695. Epub 2020 Apr 29.
3
Detection of the p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma.
Front Oncol. 2018 Sep 20;8:382. doi: 10.3389/fonc.2018.00382. eCollection 2018.
4
Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.
BMC Cancer. 2024 Apr 2;24(1):407. doi: 10.1186/s12885-024-12191-z.
5
The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid.
Hematol Oncol. 2018 Apr;36(2):429-435. doi: 10.1002/hon.2489. Epub 2017 Dec 6.
6
L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker.
Ann Lab Med. 2025 Jun 27. doi: 10.3343/alm.2024.0644.
7
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.
Br J Haematol. 2025 Jul;207(1):92-100. doi: 10.1111/bjh.20099. Epub 2025 Apr 22.
8
Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
Ocul Immunol Inflamm. 2021 Apr 3;29(3):448-455. doi: 10.1080/09273948.2019.1657903. Epub 2019 Oct 11.
9
Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma.
Cancer Sci. 2023 Jun;114(6):2544-2551. doi: 10.1111/cas.15762. Epub 2023 Mar 1.
10
Highly sensitive mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Haematologica. 2018 Jun;103(6):1029-1037. doi: 10.3324/haematol.2017.186528. Epub 2018 Mar 22.
本文引用的文献
1
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol. 2024 May 14. doi: 10.1016/j.annonc.2023.11.010.
2
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
Neuro Oncol. 2024 Jun 3;26(6):993-1011. doi: 10.1093/neuonc/noae032.
3
Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.
Br J Haematol. 2023 Jun;201(6):1088-1096. doi: 10.1111/bjh.18758. Epub 2023 Mar 20.
4
Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma.
Cancer Sci. 2023 Jun;114(6):2544-2551. doi: 10.1111/cas.15762. Epub 2023 Mar 1.
5
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
J Clin Oncol. 2023 Mar 20;41(9):1684-1694. doi: 10.1200/JCO.22.00826. Epub 2022 Dec 21.
6
High Detection Rate of Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas.
JCO Precis Oncol. 2019 Dec;3:1-13. doi: 10.1200/PO.18.00308.
7
Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma.
Cancer Sci. 2021 Nov;112(11):4702-4710. doi: 10.1111/cas.15133. Epub 2021 Sep 27.
8
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Br J Haematol. 2021 May;193(3):497-505. doi: 10.1111/bjh.17357. Epub 2021 Feb 23.
9
CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
J Neurol. 2021 Aug;268(8):2890-2894. doi: 10.1007/s00415-021-10453-5. Epub 2021 Feb 20.
10
MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.
Br J Haematol. 2019 Jun;185(5):974-977. doi: 10.1111/bjh.15674. Epub 2018 Nov 8.
Zotero 插件